ORIGINAL RESEARCH
Accepted on 07 Jan 2025
Baricitinib treatment for hospitalized patients with severe COVID-19 on invasive mechanical ventilation：a propensity score-matched and retrospective analysis
doi 10.3389/fmed.2025.1445809
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Targeting Cellular Signalling Pathways for Disease Therapy: The Potential of Cellular Reprogramming and Protein Kinase Inhibitors
Targeting Cellular Signalling Pathways for Disease Therapy: The Potential of Cellular Reprogramming and Protein Kinase Inhibitors
2,286
Total downloads
8,465
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 22 Oct 2024
Sodium danshensu modulates skeletal muscle fiber type formation and metabolism by inhibiting pyruvate kinase M1
doi 10.3389/fphar.2024.1467620
- 494 views
REVIEW
Published on 20 Sep 2024
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?
doi 10.3389/fphar.2024.1441938
- 696 views
ORIGINAL RESEARCH
Published on 08 Jul 2024
Wogonin protects against bleomycin-induced mouse pulmonary fibrosis via the inhibition of CDK9/p53-mediated cell senescence
doi 10.3389/fphar.2024.1407891
- 1,173 views
ORIGINAL RESEARCH
Published on 22 Jan 2024
Dual inhibition of MEK and PI3Kβ/δ–a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer
doi 10.3389/fphar.2024.1331648
- 1,645 views
- 1 citation
REVIEW
Published on 05 Jan 2024
The role of the Notch signalling pathway in the pathogenesis of ulcerative colitis: from the perspective of intestinal mucosal barrier
doi 10.3389/fmed.2023.1333531
- 2,599 views
- 2 citations
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
Participating Journals
Frontiers in Medicine
- 3.1 impact factor
- 5.1 citescore
Impact
- 8,465Topic views
- 5,600Article views
- 2,286Article downloads